[1]. Nationwide survey of adult patients with pulmonary alveolar proteinosis using the National Database of designated intractable diseases of Japan
Respiratory Investigation [巻]61 [号]3 [頁]364 -370 （2023年） [査読] 有
[DOI] [2]. Enhanced immune complex formation in the lungs of patients with dermatomyositis.
Respiratory research [巻]24 [号]1 [頁]86 （2023年） [査読] 有
[DOI] [3]. A predictive model for acute exacerbation of idiopathic interstitial pneumonias.
The European respiratory journal （2023年） [査読] 有
[DOI] [機関リポジトリ][4]. Association between increased peripheral blood CD86-positive plasmacytoid dendritic cells and immune-related adverse events in patients with non-small cell lung cancer.
Global health & medicine [巻]4 [号]6 [頁]301 -308 （2022年） [査読] 有
[DOI] [5]. Changes in the Characteristics and Outcomes of COVID-19 Patients from the Early Pandemic to the Delta Variant Epidemic: A Nationwide Population-based Study.
Emerging microbes & infections [巻]12 [号]1 [頁]1 -40 （2022年） [査読] 有
[DOI] [6]. Prognostic significance of radiological pleuroparenchymal fibroelastosis in Mycobacterium avium complex lung disease: a multicentre retrospective cohort study.
Thorax （2022年） [査読] 有
[DOI] [7]. Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases.
BMC pulmonary medicine [巻]22 [号]1 [頁]387 -387 （2022年） [査読] 有
[DOI] [8]. CD109 on Dendritic Cells Regulates Airway Hyperreactivity and Eosinophilic Airway Inflammation.
American journal of respiratory cell and molecular biology [巻]68 [号]2 [頁]201 -212 （2022年） [査読] 有
[DOI] [9]. Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians.
Respiratory investigation [巻]60 [号]6 [頁]779 -786 （2022年） [査読] 有
[DOI] [10]. Effect of Hypoxia on Pulmonary Endothelial Cells from Bleomycin-Induced Pulmonary Fibrosis Model Mice.
International journal of molecular sciences [巻]23 [号]16 （2022年） [査読] 有
[DOI] [11]. Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis.
BMC pulmonary medicine [巻]22 [号]1 [頁]290 -290 （2022年） [査読] 有
[DOI] [12]. Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer.
Journal of cancer research and clinical oncology （2022年） [査読] 有
[DOI] [13]. Idiopathic pleuroparenchymal fibroelastosis: 3-D CT assessment of upper lobe lung volume.
The European respiratory journal [巻]60 [号]6 （2022年） [査読] 有
[DOI] [14]. Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.
Therapeutic advances in chronic disease [巻]13 [頁]20406223221108395 -20406223221108395 （2022年） [査読] 有
[DOI] [15]. Prognostic implication of IgG4 and IgG1-positive cell infiltration in the lung in patients with idiopathic interstitial pneumonia.
Scientific reports [巻]12 [号]1 [頁]9303 -9303 （2022年） [査読] 有
[DOI] [16]. Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis.
Respiratory research [巻]23 [号]1 [頁]142 -142 （2022年） [査読] 有
[DOI] [17]. Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium.
BMC pulmonary medicine [巻]22 [号]1 [頁]186 -186 （2022年） [査読] 有
[DOI] [18]. Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study.
Respiratory research [巻]23 [号]1 [頁]79 -79 （2022年） [査読] 有
[DOI] [19]. Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis.
Thorax [巻]77 [号]7 [頁]727 -730 （2022年） [査読] 有
[DOI] [機関リポジトリ][20]. Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report.
Respiratory medicine case reports [巻]37 [頁]101632 -101632 （2022年） [査読] 有
[DOI] [21]. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.
Respiratory research [巻]23 [号]1 [頁]57 -57 （2022年） [査読] 有
[DOI] [22]. Multiple organ infarction caused by aortic thrombus in a lung cancer patient with the mutation.
Respiratory medicine case reports [巻]36 [頁]101608 （2022年） [査読] 有
[DOI] [23]. Involvement of autophagy in exacerbation of eosinophilic airway inflammation in a murine model of obese asthma.
Autophagy [巻]18 [号]9 [頁]1 -13 （2022年） [査読] 有
[DOI] [24]. EGFR-Mutated Lung Adenocarcinoma Successfully Treated With Osimertinib After Spontaneous Transformation to SCLC and Adenocarcinoma With Neuroendocrine Differentiation: Case Report
JTO clinical and research reports [巻]3 [号]1 [頁]100264 （2022年） [査読] 有
[DOI] [25]. Marked, Lasting Disease Regression and Concomitantly Induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in a Patient With Lung Adenocarcinoma and Autoantibodies Receiving Atezolizumab Plus Chemotherapy: A Case Report.
JTO clinical and research reports [巻]3 [号]1 [頁]100263 -100263 （2022年） [査読] 有
[DOI] [26]. Outcomes of COVID-19 in the Omicron-predominant wave: large-scale real-world data analysis with a comparison to influenza.
Pneumonia (Nathan Qld.) [巻]17 [号]1 [頁]3 （2025年） [査読] 有
[27]. Association of interstitial lung abnormalities with cytotoxic agent-induced pneumonitis in patients with malignancy.
Respiratory medicine [頁]107924 （2024年） [査読] 有
[28]. Deep Learning for Predicting Acute Exacerbation and Mortality of Interstitial Lung Disease.
Annals of the American Thoracic Society （2024年） [査読] 有
[29]. The providing multidisciplinary ILD diagnoses (PROMISE) study - study design of the national registry of Japan facilitating interactive online multidisciplinary discussion diagnosis.
BMC pulmonary medicine [巻]24 [号]1 [頁]511 （2024年） [査読] 有
[DOI] [30]. Antifibrotics and mortality in idiopathic pulmonary fibrosis: external validity and avoidance of immortal time bias.
Respiratory research [巻]25 [号]1 [頁]293 （2024年） [査読] 有
[DOI] [31]. Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy.
Cancer immunology, immunotherapy : CII （2023年） [査読] 有
[DOI] [32]. Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias.
Thorax [巻]77 [号]2 [頁]143 -153 （2022年） [査読] 有
[DOI] [33]. Transient leukocytopenia following combination therapy for COVID-19.
Respiratory investigation [巻]60 [号]1 [頁]158 -161 （2022年） [査読] 有
[DOI] [34]. Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer.
Cancer immunology, immunotherapy : CII [巻]71 [号]1 [頁]203 -217 （2022年） [査読] 有
[DOI] [35]. Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy.
BMC pulmonary medicine [巻]21 [号]1 [頁]409 -409 （2021年） [査読] 有
[DOI] [36]. Response.
Chest [巻]160 [号]6 [頁]e683-e685 （2021年） [査読] 有
[DOI] [37]. Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis.
Chest [巻]160 [号]6 [頁]2149 -2157 （2021年） [査読] 有
[DOI] [機関リポジトリ][38]. Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias.
Respiratory research [巻]22 [号]1 [頁]290 -290 （2021年） [査読] 有
[DOI] [39]. Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis.
Respiratory investigation [巻]59 [号]6 [頁]827 -836 （2021年） [査読] 有
[DOI] [機関リポジトリ][40]. MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
JTO clinical and research reports [巻]2 [号]11 [頁]100239 （2021年） [査読] 有
[DOI] [41]. Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab Therapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) （2021年） [査読] 有
[DOI] [42]. Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis.
BMC pulmonary medicine [巻]21 [号]1 [頁]309 -309 （2021年） [査読] 有
[DOI] [43]. 【鑑別診断を意識した-非専門医のための胸部画像診断】画像パターンから攻める 多発嚢胞なのか,気腫なのか,蜂巣肺なのか
Medicina (株)医学書院 [巻]58 [号]11 [頁]1834 -1840 （2021年） [査読] 有
[DOI] [44]. Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis.
Scientific reports [巻]11 [号]1 [頁]18579 -18579 （2021年） [査読] 有
[DOI] [45]. Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertension.
Scientific reports [巻]11 [号]1 [頁]15502 -15502 （2021年） [査読] 有
[DOI] [46]. Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas.
Scientific reports [巻]11 [号]1 [頁]14999 -14999 （2021年） [査読] 有
[DOI] [47]. Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study.
BMC pulmonary medicine [巻]21 [号]1 [頁]221 -221 （2021年） [査読] 有
[DOI] [48]. Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung.
Allergology international : official journal of the Japanese Society of Allergology [巻]70 [号]3 [頁]351 -359 （2021年） [査読] 有
[DOI] [49]. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
Chest [巻]159 [号]6 [頁]2334 -2345 （2021年） [査読] 有
[DOI] [機関リポジトリ][50]. Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease.
Respiratory medicine [巻]182 [頁]106420 -106420 （2021年） [査読] 有
[DOI] [51]. Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study.
Scientific reports [巻]11 [号]1 [頁]9120 -9120 （2021年） [査読] 有
[DOI] [52]. Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray.
Scientific reports [巻]11 [号]1 [頁]7669 -7669 （2021年） [査読] 有
[DOI] [53]. Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes.
Journal of clinical medicine [巻]10 [号]7 （2021年） [査読] 有
[DOI] [54]. Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
Respirology (Carlton, Vic.) [巻]26 [号]4 [頁]370 -377 （2021年） [査読] 有
[DOI] [55]. Risk Factors for Pneumonia and Death in Adult Patients With Seasonal Influenza and Establishment of Prediction Scores: A Population-Based Study.
Open forum infectious diseases [巻]8 [号]3 [頁]ofab068 （2021年） [査読] 有
[DOI] [56]. Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study.
Thorax [巻]76 [号]3 [頁]248 -255 （2021年） [査読] 有
[DOI] [57]. Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival.
BMC pulmonary medicine [巻]21 [号]1 [頁]63 -63 （2021年） [査読] 有
[DOI] [58]. Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy.
Respirology (Carlton, Vic.) [巻]26 [号]2 [頁]171 -179 （2021年） [査読] 有
[DOI] [機関リポジトリ][59]. Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infection.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [巻]27 [号]2 [頁]373 -378 （2021年） [査読] 有
[DOI] [機関リポジトリ][60]. Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations.
Investigational new drugs [巻]39 [号]1 [頁]210 -216 （2021年） [査読] 有
[DOI] [機関リポジトリ][61]. Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [巻]23 [号]2 [頁]418 -423 （2021年） [査読] 有
[DOI] [62]. Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease.
Scientific reports [巻]11 [号]1 [頁]1682 -1682 （2021年） [査読] 有
[DOI] [63]. Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk Factors.
Respiration; international review of thoracic diseases [巻]100 [号]1 [頁]19 -26 （2021年） [査読] 有
[DOI] [64]. Prophylactic granulocyte-colony stimulating factor in patients with lung neuroendocrine carcinoma receiving platinum agents plus etoposide.
Cancer treatment and research communications [巻]29 [頁]100493 -100493 （2021年） [査読] 有
[DOI] [65]. Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epithelium.
Respiratory research [巻]21 [号]1 [頁]282 -282 （2020年） [査読] 有
[DOI] [66]. Clinical, radiological, and pathological evaluation of "NSIP with OP overlap" pattern compared with NSIP in patients with idiopathic interstitial pneumonias.
RESPIRATORY MEDICINE [巻]174 [頁]106201 （2020年） [査読] 有
[DOI] [機関リポジトリ][67]. Development of a novel T cell-oriented vaccine using CTL/Th-hybrid epitope long peptide and biodegradable microparticles, against an intracellular bacterium.
Microbiology and immunology [巻]64 [号]10 [頁]666 -678 （2020年） [査読] 有
[DOI] [68]. 【間質性肺炎:診断と治療のup to date】特発性肺線維症の特徴と診断プロセス
炎症と免疫 (株)先端医学社 [巻]28 [号]6 [頁]482 -488 （2020年）
[69]. Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis
Therapeutic Advances in Respiratory Disease [巻]14 （2020年） [査読] 有
[DOI] [70]. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis.
Respiratory medicine [巻]171 [頁]106078 -106078 （2020年） [査読] 有
[DOI] [機関リポジトリ][71]. Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non-small Cell Lung Cancer.
JAMA network open [巻]3 [号]9 [頁]e2011818 （2020年） [査読] 有
[DOI] [72]. Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.
Respirology (Carlton, Vic.) [巻]25 [号]7 [頁]743 -749 （2020年） [査読] 有
[DOI] [73]. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
Therapeutic Advances in Respiratory Disease [巻]14 （2020年） [査読] 有
[DOI] [74]. Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' View
J Pain Symptom Manage [巻]60 [号]5 [頁]933 -940 （2020年） [査読] 有
[DOI] [機関リポジトリ][75]. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis.
Respiratory investigation [巻]58 [号]3 [頁]177 -184 （2020年） [査読] 有
[DOI] [機関リポジトリ][76]. Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) [巻]143 [頁]47 -54 （2020年） [査読] 有
[DOI] [機関リポジトリ][77]. Assessment of Immune-Related Interstitial Lung Disease in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Multi-Center Prospective Study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [巻]15 [号]8 [頁]1317 -1327 （2020年） [査読] 有
[DOI] [機関リポジトリ][78]. Pulse oximetric saturation to fraction of inspired oxygen (SpO/FIO) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620906327 （2020年） [査読] 有
[DOI] [79]. Pneumothorax in connective tissue disease-associated interstitial lung disease.
PloS one [巻]15 [号]7 [頁]e0235624 （2020年） [査読] 有
[DOI] [80]. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620935774 -1753466620935774 （2020年） [査読] 有
[DOI] [81]. Clinical, radiological, and pathological evaluation of "NSIP with OP overlap" pattern compared with NSIP in patients with idiopathic interstitial pneumonias.
Respiratory medicine [巻]174 [頁]106201 -106201 （2020年） [査読] 有
[DOI] [82]. Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620953783 -1753466620953783 （2020年） [査読] 有
[DOI] [83]. Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia.
Scientific reports [巻]9 [号]1 [頁]18750 -18750 （2019年） [査読] 有
[DOI] [84]. 市中肺炎に対するレボフロキサシン・スイッチ療法の有効性・安全性の検討(Intravenous to Oral Levofloxacin Switch Therapy in Patients with Moderate Community-acquired Pneumonia: A Pilot Study)
新薬と臨牀 (株)医薬情報研究所 [巻]68 [号]12 [頁]1519 -1531 （2019年） [査読] 無
[85]. Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD.
Rheumatology (Oxford, England) [巻]58 [号]12 [頁]2143 -2152 （2019年） [査読] 有
[DOI] [86]. Simultaneous Occurrence of Sarcoidosis and Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis in a Patient with Lung Cancer.
Internal medicine (Tokyo, Japan) [巻]58 [号]22 [頁]3299 -3304 （2019年） [査読] 有
[DOI] [87]. Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer.
Internal medicine (Tokyo, Japan) [巻]58 [号]22 [頁]3267 -3271 （2019年） [査読] 有
[DOI] [88]. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
Respiratory medicine [巻]159 [頁]105811 -105811 （2019年） [査読] 有
[DOI] [89]. Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.
Respiratory investigation [巻]57 [号]6 [頁]552 -560 （2019年） [査読] 有
[DOI] [90]. Body composition changes successfully classify prognosis in patients with mycobacterium avium complex lung disease.
The Journal of infection [巻]79 [号]4 [頁]341 -348 （2019年） [査読] 有
[DOI] [91]. 【びまん性肺疾患診療の新しい展開】膠原病関連びまん性肺疾患
臨牀と研究 大道学館出版部 [巻]96 [号]10 [頁]1189 -1197 （2019年）
[URL] [92]. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
The Journal of rheumatology [巻]46 [号]8 [頁]935 -942 （2019年） [査読] 有
[DOI] [93]. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Respirology (Carlton, Vic.) [巻]24 [号]8 [頁]792 -798 （2019年） [査読] 有
[DOI] [94]. Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Scientific reports [巻]9 [号]1 [頁]10484 -10484 （2019年） [査読] 有
[DOI] [95]. Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting.
Cancer chemotherapy and pharmacology [巻]84 [号]1 [頁]147 -153 （2019年） [査読] 有
[DOI] [96]. Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Investigational new drugs [巻]37 [号]3 [頁]531 -537 （2019年） [査読] 有
[DOI] [97]. Physiological and morphological differences of airways between COPD and asthma-COPD overlap.
Scientific reports [巻]9 [号]1 [頁]7818 -7818 （2019年） [査読] 有
[DOI] [98]. Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion.
The European respiratory journal [巻]53 [号]5 （2019年） [査読] 有
[DOI] [99]. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
The Journal of rheumatology [巻]46 [号]5 [頁]509 -517 （2019年） [査読] 有
[DOI] [100]. Methotrexate-associated Lymphoproliferative Disorder with Diffuse Ground-Glass Opacities.
American journal of respiratory and critical care medicine [巻]199 [号]8 [頁]1031 -1033 （2019年） [査読] 有
[DOI] [101]. 【診療力を上げる! 症例問題集】(第1章)呼吸器 症例問題 皮疹とともに進行性の呼吸困難・胸部異常陰影を呈した1例
内科 (株)南江堂 [巻]123 [号]4 [頁]511 -512 （2019年） [査読] 無
[DOI] [102]. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
Chronic respiratory disease [巻]16 [頁]1479972318809476 -1479972318809476 （2019年） [査読] 有
[DOI] [103]. Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease.
International journal of chronic obstructive pulmonary disease [巻]14 [頁]1333 -1342 （2019年） [査読] 有
[DOI] [104]. Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.
Respiratory medicine [巻]154 [頁]102 -108 （2019年） [査読] 有
[DOI] [105]. Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial.
Journal of asthma and allergy [巻]12 [頁]253 -261 （2019年） [査読] 有
[DOI] [106]. Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD.
International journal of chronic obstructive pulmonary disease [巻]14 [頁]1867 -1877 （2019年） [査読] 有
[DOI] [107]. Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease.
Respiratory medicine [巻]146 [頁]76 -80 （2019年） [査読] 有
[DOI] [108]. Differences in airway structural changes assessed by 3-dimensional computed tomography in asthma and asthma-chronic obstructive pulmonary disease overlap.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [巻]121 [号]6 [頁]704 -710 （2018年） [査読] 有
[DOI] [109]. An Acquired Epidermal Growth Factor Receptor T790M Mutation after the Addition of Bevacizumab to Preceding Erlotinib Monotherapy in a Lung Cancer Patient with Leptomeningeal Metastases.
Internal medicine (Tokyo, Japan) [巻]57 [号]23 [頁]3423 -3427 （2018年） [査読] 有
[DOI] [110]. 【ステロイドの使い方と注意点】呼吸器疾患におけるステロイド薬の適応と意義
成人病と生活習慣病 (株)東京医学社 [巻]48 [号]11 [頁]1211 -1218 （2018年）
[URL] [111]. IL-17A Attenuates IFN-λ Expression by Inducing Suppressor of Cytokine Signaling Expression in Airway Epithelium.
Journal of immunology (Baltimore, Md. : 1950) [巻]201 [号]8 [頁]2392 -2402 （2018年） [査読] 有
[DOI] [112]. 多発性筋炎・皮膚筋炎の間質性肺疾患における新規バイオマーカーの探索 YKL-40の臨床的有用性
リウマチ科 (有)科学評論社 [巻]60 [号]4 [頁]418 -426 （2018年）
[113]. Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis.
Scientific reports [巻]8 [号]1 [頁]14074 -14074 （2018年） [査読] 有
[DOI] [114]. Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis.
Medical oncology (Northwood, London, England) [巻]35 [号]11 [頁]139 -139 （2018年） [査読] 有
[DOI] [115]. Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis.
Scientific reports [巻]8 [号]1 [頁]13129 -13129 （2018年） [査読] 有
[DOI] [116]. 【特発性間質性肺炎の診療の現状と将来展望】膠原病の匂いのする間質性肺疾患 IPAFを中心に
呼吸臨床 COSMIC [巻]2 [号]8 [頁]1/10 -10/10 （2018年）
[117]. Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis.
The clinical respiratory journal [巻]12 [号]8 [頁]2378 -2389 （2018年） [査読] 有
[DOI] [118]. Anti-PL-7 Antisynthetase Syndrome with Eosinophilic Pleural Effusion.
Internal medicine (Tokyo, Japan) [巻]57 [号]15 [頁]2227 -2232 （2018年） [査読] 有
[DOI] [119]. Neurogenic Pulmonary Edema without Norepinephrine Elevation.
Internal medicine (Tokyo, Japan) [巻]57 [号]14 [頁]2097 -2098 （2018年） [査読] 有
[DOI] [120]. Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study.
Medical oncology (Northwood, London, England) [巻]35 [号]7 [頁]108 -108 （2018年） [査読] 有
[DOI] [121]. Neutrophil gelatinase-associated lipocalin in patients with sarcoidosis.
Respiratory medicine [巻]138S [頁]S20-S23 （2018年） [査読] 有
[DOI] [122]. Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia.
Respiratory medicine [巻]137 [頁]167 -175 （2018年） [査読] 有
[DOI] [123]. Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease.
PloS one [巻]13 [号]6 [頁]e0198479 （2018年） [査読] 有
[DOI] [124]. Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias.
PloS one [巻]13 [号]6 [頁]e0199659 （2018年） [査読] 有
[DOI] [125]. Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study.
Respiratory medicine [巻]133 [頁]1 -5 （2017年） [査読] 有
[DOI] [126]. Persistent impairment on spirometry in chronic eosinophilic pneumonia: A longitudinal observation study (Shizuoka-CEP study).
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [巻]119 [号]5 [頁]422 -428 （2017年） [査読] 有
[DOI] [127]. 【肺血管炎の基礎と臨床】顕微鏡的多発血管炎の肺病変 診断と治療
呼吸器内科 (有)科学評論社 [巻]32 [号]4 [頁]314 -324 （2017年）
[128]. Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
The Journal of rheumatology [巻]44 [号]9 [頁]1394 -1401 （2017年） [査読] 有
[DOI] [129]. Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated with Erlotinib and Oral Fluoropyrimidine.
Internal medicine (Tokyo, Japan) [巻]56 [号]17 [頁]2367 -2371 （2017年） [査読] 有
[DOI] [130]. Relationship between fraction of exhaled nitric oxide and airway morphology assessed by three-dimensional CT analysis in asthma.
Scientific reports [巻]7 [号]1 [頁]10187 -10187 （2017年） [査読] 有
[DOI] [131]. Type-1 polarised dendritic cells are a potent immunogen against .
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [巻]21 [号]5 [頁]523 -530 （2017年）
[DOI] [132]. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
Respiratory investigation [巻]55 [号]2 [頁]130 -137 （2017年） [査読] 有
[DOI] [133]. Respiratory impedance is correlated with morphological changes in the lungs on three-dimensional CT in patients with COPD.
Scientific reports [巻]7 [頁]41709 -41709 （2017年） [査読] 有
[DOI] [134]. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
Arthritis research & therapy [巻]19 [号]1 [頁]9 -9 （2017年） [査読] 有
[DOI] [135]. Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease.
PloS one [巻]12 [号]6 [頁]e0180283 （2017年） [査読] 有
[DOI] [136]. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
Respiratory medicine [巻]121 [頁]91 -99 （2016年） [査読] 有
[DOI] [137]. Soluble hemoglobin scavenger receptor CD163 (sCD163) predicts mortality of community-acquired pneumonia.
The Journal of infection [巻]73 [号]4 [頁]375 -7 （2016年） [査読] 有
[DOI] [138]. Gastrointestinal Bleeding From Duodenal Aberrant Pancreas After Antiangiogenic Therapy.
Journal of clinical gastroenterology [巻]50 [号]8 [頁]689 -90 （2016年） [査読] 有
[DOI] [139]. Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease.
Respiratory medicine [巻]117 [頁]40 -7 （2016年） [査読] 有
[DOI] [140]. Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosis.
Respiratory medicine [巻]115 [頁]46 -52 （2016年） [査読] 有
[DOI] [141]. Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias.
Lung [巻]194 [号]2 [頁]235 -42 （2016年） [査読] 有
[DOI] [142]. Crowned dens syndrome.
Acute medicine & surgery [巻]2 [号]4 [頁]273 -273 （2015年） [査読] 有
[DOI] [143]. 間質性肺疾患におけるUCTD診断の臨床的意義
呼吸器内科 (有)科学評論社 [巻]27 [号]4 [頁]298 -303 （2015年）
[144]. 【ステロイド薬(含吸入薬)の基礎と呼吸器疾患への臨床応用】間質性肺炎 膠原病に合併した間質性肺疾患に対する治療戦略
日本胸部臨床 克誠堂出版(株) [巻]74 [号]4 [頁]411 -425 （2015年）
[145]. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
PloS one [巻]10 [号]3 [頁]e0120313 （2015年） [査読] 有
[DOI] [146]. 【肺血管炎の基礎と臨床】顕微鏡的多発血管炎の病態、肺病変の特徴、治療
呼吸器内科 (有)科学評論社 [巻]25 [号]4 [頁]294 -302 （2014年）
[147]. Prognostic factors for myositis-associated interstitial lung disease.
PloS one [巻]9 [号]6 [頁]e98824 （2014年） [査読] 有
[DOI] [148]. Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study.
BMJ open [巻]3 [号]9 [頁]e003132 （2013年） [査読] 有
[DOI] [149]. 【2次性間質性肺炎の画像診断をめぐって】膠原病的特徴を持つ間質性肺炎の臨床像と画像所見 NSIP、UCTD、lung dominant CTD、膠原病の肺病変をめぐって
日本胸部臨床 克誠堂出版(株) [巻]72 [号]9 [頁]934 -948 （2013年）
[150]. Immunogenicity of dormancy-related antigens in individuals infected with Mycobacterium tuberculosis in Japan.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [巻]17 [号]6 [頁]818 -24 （2013年） [査読] 有
[DOI] [151]. 【特発性間質性肺炎を見直す-特発性間質性肺炎臨床の最新知見】NSIPとUCTD
呼吸と循環 (株)医学書院 [巻]61 [号]2 [頁]123 -131 （2013年）
[URL] [152]. Respiratory mechanics measured by forced oscillation technique in combined pulmonary fibrosis and emphysema.
Respiratory physiology & neurobiology [巻]185 [号]2 [頁]235 -40 （2013年） [査読] 有
[DOI] [153]. Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases.
Respiratory medicine [巻]106 [号]8 [頁]1164 -9 （2012年） [査読] 有
[DOI] [154]. Ulcerating bronchitis caused by cytomegalovirus in a patient with polymyositis.
Internal medicine (Tokyo, Japan) [巻]51 [号]20 [頁]2933 -6 （2012年） [査読] 有
[155]. Nonspecific interstitial pneumonia: prognostic significance of high-resolution computed tomography in 59 patients.
Journal of computer assisted tomography [巻]35 [号]5 [頁]583 -9 （2011年） [査読] 有
[DOI] [156]. 成人に発症したInfectious bronchiolitisの2例
静岡県立総合病院医学雑誌 静岡県立総合病院 [巻]22 [号]1 [頁]25 -30 （2010年）
[157]. プロブレムで考える症例検討会
日本内科学会雑誌 (一社)日本内科学会 [巻]97 [号]11 [頁]2811 -2819 （2008年）
[URL] [158]. 重症持続型喘息におけるサルメテロール/フルチカゾンプロピオン酸エステル配合剤(SFC)の有用性 単一デバイスによる相乗作用
アレルギー・免疫 (株)医薬ジャーナル社 [巻]15 [号]10 [頁]1424 -1429 （2008年）
[159]. 肺アスペルギルス症におけるI型アレルギーの意義
アレルギーの臨床 (株)北隆館 [巻]28 [号]9 [頁]784 -789 （2008年）
[160]. 小麦が原因と考えられた食物依存性運動誘発アナフィラキシーの1例
静岡県立総合病院医学雑誌 静岡県立総合病院 [巻]21 [号]1 [頁]35 -37 （2008年）
[161]. 小麦に対する接触皮膚炎および食物アレルギーを合併した職業性小麦粉喘息の1例
静岡県立総合病院医学雑誌 静岡県立総合病院 [巻]21 [号]1 [頁]29 -33 （2008年）
[162]. 脳圧亢進と中枢性Na利尿の関連が示唆された脳膿瘍の1例
日本内科学会雑誌 (一社)日本内科学会 [巻]93 [号]4 [頁]768 -770 （2004年）
[URL]